- Previous Close
0.0250 - Open
0.0500 - Bid 0.0400 x --
- Ask 0.0700 x --
- Day's Range
0.0200 - 0.0500 - 52 Week Range
0.0100 - 0.0800 - Volume
14,000 - Avg. Volume
269 - Market Cap (intraday)
2.412M - Beta (5Y Monthly) 0.63
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Nirvana Life Sciences Inc. engages in the scientific research and development of therapeutic products derived from psychedelics. It also focuses on developing methodologies for extraction and purification of psychoactive compounds. The company is headquartered in Vancouver, Canada.
nirvanalifescience.comRecent News: NIRV.CN
View MorePerformance Overview: NIRV.CN
Trailing total returns as of 12/27/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NIRV.CN
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NIRV.CN
View MoreValuation Measures
Market Cap
2.41M
Enterprise Value
2.43M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-197.82%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-1.23M
Diluted EPS (ttm)
-0.0300
Balance Sheet and Cash Flow
Total Cash (mrq)
3.14k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
4.31k